Procter & Gamble Hygiene and Health Care Ltd. announced its financial results for the third quarter and the fiscal year ended March 31, 2025.

Despite a continually challenging operating and macro-economic environment, for the 9-month fiscal year ended March 31, 2025, the company reported sales of Rs. 3, 374 crore, up 3% versus the comparable 9-month period last year. Profit After Tax (PAT) was Rs. 636 crores, up 7% versus the comparable period last year. These results were driven by a robust portfolio and innovation to meet evolving consumer needs.

Considering that the company, effective this year, changed its Financial Year from July 1 – June 30 to April 1 – March 31, the current Financial Year of the company covers a period of 9 months, from July 1, 2024, to March 31, 2025. The company performance has therefore been indexed versus the comparable 9-months period in the last year (July 1, 2023, to March 31, 2024). The performance versus a 12-month past fiscal will not be comparable.

The company also announced results for the third quarter, reporting sales at Rs. 992 crore, flat versus year ago. Profit After Tax (PAT) for the quarter was Rs. 156 crore.

V Kumar, Managing Director, Procter & Gamble Hygiene and Health Care Ltd. shared, “The year witnessed a continued challenging operating and macroeconomic environment, where we delivered balanced growth. We also continued to introduce innovations in the pursuit of delivering superior experiences to our consumers, across both feminine care and health care portfolios. We remain focused on executing our integrated growth strategy– a product portfolio of categories where performance drives brand choice, superiority (of product performance, packaging, brand communication, retail execution and consumer and customer value), productivity, constructive disruption, and an agile and accountable organization – towards long term value creation.”

The Board of Directors have recommended a final dividend of Rs. 65/- per Equity Share for the Financial Year ended March 31, 2025, subject to the approval of Shareholders of the company at the ensuing 61^st Annual General Meeting. Considering the interim dividend of ₹110 per share, the total dividend payout for the fiscal will be Rs. 175 per share, subject to shareholder approval.

The company’s business continues to grow behind a strong suite of product innovations keeping the consumers at the centre. This includes the new Whisper Ultra – No Gaps, No Leaks Sanitary Pads - featuring world’s first Curvewear Technology with a unique raised center for a seamless fit that enhances consumer convenience. Whisper Choice portfolio moved to a softer, cottony top sheet offering consumers a more comfortable experience. An upgraded Vicks Vaporub continues to delight consumers and enables a peaceful night’s sleep. Vicks Cough Drops Double Power delivers a more effective and longer lasting relief from sore throat.

During the year, the company continued to contribute to flagship CSR program of the P&G group, P&G Shiksha and positively impact communities it serves and operates in. Celebrating two decades of working with thousands of communities, P&G Shiksha is impacting more than 50 lakh children since its inception.